The complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
|
It was reported to boston scientific corporation that spaceoar vue was implanted during a spaceoar vue placement procedure performed on (b)(6) 2021.The procedure was done under general anesthesia.The procedure was done via remote support with the spaceoar training manager.According to physician standard surgical precautions, drapes, skin disinfection, prophylactic ciprofloxacin were taken as per protocol and no issues or concerns during the case.On (b)(6) 2021, the patient was presented with loss of appetite and fever.During radiation treatment, the patient developed increasing lower urinary tract symptoms and acute urinary retention after 11 of planned 20 treatments.His radiation treatment was put on hold.Diagnostic computerized tomography (ct) scan was performed and it showed a pelvice collection in the perineum and extending in continuity to the spacer.No bowel symptoms to report.In the physician's assessment, it was likely that the infection/abscess was related to the spaceoar procedure.The urinary retention, loss of appetite, fever, pelvic collection, and increasing lower urinary tract symptoms were caused by perineal abscess patient was hospitalized.He was put on intravenous (iv) antibiotics and was catheterized.He was also scheduled for radiological drainage on (b)(6) 2021.Additionally, patient had incision and drainage, and clinically has improved.He now has regular dressing changes of his perineal wound.Radiation has not been able to resume as yet but was planned to do so in a few weeks time.
|